Home > Healthcare & Medical Devices > Compression Therapy Market
Compression Therapy Market size was worth more than USD 2.5 million in 2022 and is set to grow at a robust pace of over 5% CAGR from 2023 and 2032 owing to the escalating number of road accidents and sports injuries.
To get more details on this report: Request Free Sample PDF
Sports injuries have increased resulting from a growing number of adults and kids engaging in more physical exercise. Over 30 million kids and teenagers play organized sports in the U.S. each year, and more than 3.5 million people get hurt as a result. As athletes and sports trainers seek quicker and more controlled recovery, the increasing number of sports injuries and accidents has led to the growth in hospitalization for compression therapy, which is the key driver propelling the market landscape.
Report Coverage | Details |
---|---|
Base Year: | 2022 |
Market Size in 2022: | USD 2.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.5% |
2032 Value Projection: | USD 4 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 250 |
Tables, Charts & Figures: | 425 |
Segments covered: | Product, Technology, Application and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
To get more details on this report: Request Free Sample PDF
Compression therapy is the standard diagnostic therapeutic strategy for venous problems, lymphedema, oedema, and other diseases. Oral treatments and surgical approaches, on the other hand, are recommended for people who are non-responsive or non-compliant with compression therapy. Patients with venous leg ulcers (VLU) who are not adherent to compression therapy, particularly elderly persons, prefer oral therapy. Thus, the availability of several surgical and therapeutic options to compression therapy as alternatives may restrict market expansion. However, investments in R&D initiatives to provide improved therapy solutions are expected to help overcome the market restraint.
To get more details on this report: Request Free Sample PDF
Based on product, the compression therapy market from the compression garments segment accounted for more than USD 1 billion in revenue in 2022. The segment expansion is projected to be mainly fueled by the rising prevalence of orthopedic disorders caused by an increase in the number of accidents and traffic injuries. The rising number of sports injuries has also contributed to the increased popularity of athletic compression garments, which offers additional support for muscles and joints and promotes rapid recovery. The growing adoption of compression clothing by athletes to aid in improved blood circulation before or after workouts is also anticipated to strengthen market outlook.
In terms of technology, the compression therapy market from the static compression therapy segment is anticipated to reach over USD 3.5 billion by 2032 due to the rising prevalence of vascular ailments and a surge in the number of deep vein thrombosis (DVT) patients. For instance, in the United States, DVT or pulmonary embolism (PE) affects as many as 900,000 people annually. Static compression therapy is a proven treatment option for DVT, resulting in the mounting demand for the therapy, which is expected to stimulate segment revenue.
By application, the varicose vein treatment segment held more than 36% revenue share in the compression therapy market in 2022 and is poised to exhibit a robust growth rate through 2032. The varicose vein is the most reported medical issue, causing significant morbidity and long-term medical expenses for the patient. Varicose veins are prevalent globally owing to the expanding geriatric population base, the current sedentary lifestyle, and the lack of physical exercise.
To get more details on this report: Request Free Sample PDF
North America global compression therapy market held around 33% industry share in 2022 and is projected to generate lucrative gains by 2032 attributable to several factors, including an increase in the number of surgical operations, an increase in the frequency of venous diseases, and favorable government efforts. Moreover, the presence of major industry players and their ongoing efforts to develop cost-effective and innovative products is likely to stimulate the regional revenue share.
Convatech, Inc., Arjohuntleigh, Paul Hartmann AG, 3M Company, Alcare Company Ltd., DJO Global Inc. (Colfax Corporation), Cardinal Health, Inc., Essity, Julius Zorn GmbH, Sanyleg S.R.L., Tactile Medical, and Sigvaris, are some of the major players operating in the compression therapy industry. These firms usually engage in strategic initiatives to enhance their market standing, such as collaborations and portfolio expansions.
Click here to Buy Section of this Report
By Product
By Technology
By Application
The above information is provided for the following regions and countries: